Effect of naloxone on serum testosterone in adult male rabbits

Archives of Andrology

Volumn 37, Issue 1, 1996, Pages 15-18

  Pedron N ^a   Pedroza, D ^a   Calzada, L ^a   Salazar, L ^a   Fuentes, V ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Endogenous opioid peptides; Naloxone; Testosterone

Indexed keywords

ENDORPHIN; GONADORELIN; NALOXONE; NALTREXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; SODIUM CHLORIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 79961222766     PISSN: 01485016     EISSN: None     Source Type: Journal    
DOI: 10.3109/01485019608988497     Document Type: Article

References (17)

1. Blank MS, Roberts DL (1982): Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone. Neuroendocrinology 35:309-314.
2. Bruni JF, Van Vugt D, Marshall S, Meites J (1977): Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci 21:461-466.
3. Cicero TJ, Schainker BA, Meyer ER (1979): Endogenous opiates participate in the regulation of the hypothalamic pituitary luteinizing hormone: axis and testosterone's negative feedback control of luteinizing hormone. Endocrinology 104:1286-1291.
4. Cicero TJ, Wilcox CE, Bell RD, Meyer ER (1980): Naloxone-induced increases in serum luteinizing hormone in the male: mechanisms of action. J Pharmacol Exp Ther 212:573-578.
5. DuPont A, Cusan L, Garon M, Labrie F, Li CH (1977): β-Endorphin stimulation of growth hormone release in vivo. Proc Natl Acad Sci USA 74:358-360.
6. Fraioli F, Panerai AE, Santoro C, Fabbri A, Santoro F, Isidori A (1982): Control of gonadotropin secretion in man: role of opioid peptides. Horm Metab Res 16:312-317.
7. Goldstein A (1976): Opioid peptides (endorphins) in pituitary and brain. Science 163:1081-1086.
8. Hughes J (1975): Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res 88:295-308.
9. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR (1975): Identification of two related peptides from the brain with potent opiate antagonist activity. Nature 258:577-579.
10. Karla SP (1981): Neural loci involved in naloxone-induced luteinizing hormone release: effects of a norepinephrine synthesis inhibitor. Endocrinology 109:1805-1810.
11. Ling N, Burgus R, Guillemin R (1976): Isolation, primary structure and synthesis of α-endorphin, and γ-endorphin, two peptides of hypothalamic-hypophysial origin with morphomimetic activity. Proc Natl Acad Sci USA 73:3942-3946.
12. Martin WR (1984): Naloxone. Ann Intern Med 85:765-768.
13. Morley JE, Baranetsky NG, Wingert TD, et al (1980): Endocrine effect of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab 50:251-257.
14. Pfeiffer WR, Herz A (1984): Endocrine actions of opioids. Horm Metabol Res 16:386-397.
15. Rivier C, Vale W, Ling N, Brown M, Guillemin R (1977): Stimulation in vivo of the secretion of prolactin and growth hormone by β-endorphin. Endocrinology 100:238-241.
16. Sawynoc J, Pinsky C, La Bella FS (1979): Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25:1621-1623.
17. Veldhuis JD, Rogol AD, Johnson MJ, Dufau ML (1983): Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man. J Clin Invest 72:2031-2040.